keratoconus is a progressive corneal ectatic disease characterized by paraxial stromal thinning and weakening, resulting in irregular astigmatism, corneal protrusion, and distortion of the anterior corneal surface. It is usually bilateral, although asymmetrical in most cases.

Intrastromal corneal rings are polymethylmethacrylate devices successfully used for the management of keratoconus, pellucid marginal degeneration, post-LASIK ectasia and myopia. Intrastromal corneal rings implantation is safe and reversible procedure that does not affect the central corneal area, and hence, avoids interference with visual axis. The goal of intrastromal corneal rings implantation is to improve visual acuity by regulariztion of the anterior corneal surface.

Inclusion Criteria:

• Keratoconus grade I, II and III according to the mean K Amsler-Krumeich classification.
• Contact lens intolerance.
• Thinnest location is more than 400 um.
• Maximum keratometry (Kmax) between 48 and 64 D.
• Clear cornea with no Vogt's striae.

Exclusion Criteria:

• Previous corneal surgery.
• Grade IV with corneal scarring.
• Concurrent corneal disease in addition to KC.
• Autoimmune or systemic connective tissue diseases.

patients with keratoconus implanted with the Myoring 360 degree, KeraRing 355 degree, KeraRing one segment, KeraRing two segments ICRS .corneal tomography scans of the two corneal surfaces were obtained preoperatively and postoperatively with a rotating Scheimpflug imaging system .pentacam data that will be included